Hydrochlorothiazide W/ Reserpine And Hydralazine

   
Google
 
Web NewDrugInformation.com

Hydrochlorothiazide W/ Reserpine And Hydralazine


Drug - Hydrochlorothiazide W/ Reserpine And Hydralazine
The trade name of the product as shown on the labeling.

Dosage - TABLET; ORAL
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Hydralazine Hydrochloride; Hydrochlorothiazide; Reserpine
Multiple ingredients are in alphabetical order.

Strength - 25MG;15MG;0.1MG
The potency of the active ingredient(s), Hydralazine Hydrochloride; Hydrochlorothiazide; Reserpine. May repeat for multiple part products.

Applicant - WATSON LABS
The firm name holding legal responsibility for Hydrochlorothiazide W/ Reserpine And Hydralazine. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 083770
The FDA assigned number to Hydrochlorothiazide W/ Reserpine And Hydralazine. Format is nnnnnn.

Product Number - 001
The FDA assigned number to identify Hydrochlorothiazide W/ Reserpine And Hydralazine. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code -
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Approved Prior to Jan 1, 1982
The date Hydrochlorothiazide W/ Reserpine And Hydralazine was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - No
The pioneer or innovator of Hydrochlorothiazide W/ Reserpine And Hydralazine. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - DISCN
The group or category of approved drugs Hydrochlorothiazide W/ Reserpine And Hydralazine is in. Format is RX, OTC, DISCN.

Applicant Full Name - Watson Laboratories Inc
The full name of the firm holding legal responsibility for the new application of Hydrochlorothiazide W/ Reserpine And Hydralazine.

Hydrochlorothiazide W/ Reserpine And Hydralazine